Abg Innovation Capital Partners Iii Gp LTD Idera Pharmaceuticals, Inc. Transaction History

Abg Innovation Capital Partners Iii Gp LTD

  • $1.1 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
BUY
$2.09 - $5.18 $117,562 - $291,375
56,250 New
56,250 $206,000

Others Institutions Holding IDRA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IDERA PHARMACEUTICALS, INC.

IDRA Quotes by TradingView
  • Ticker IDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,296,900
  • Market Cap $188M
  • Description
  • Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...
More about IDRA
Track This Portfolio

Track Abg Innovation Capital Partners Iii Gp LTD Portfolio

Follow Abg Innovation Capital Partners Iii Gp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abg Innovation Capital Partners Iii Gp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Abg Innovation Capital Partners Iii Gp LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email